183 related articles for article (PubMed ID: 18602825)
1. Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
Banciu M; Metselaar JM; Schiffelers RM; Storm G
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):101-10. PubMed ID: 18602825
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
Banciu M; Schiffelers RM; Fens MH; Metselaar JM; Storm G
J Control Release; 2006 Jun; 113(1):1-8. PubMed ID: 16707187
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.
Banciu M; Fens MH; Storm G; Schiffelers RM
J Control Release; 2008 Apr; 127(2):131-6. PubMed ID: 18291548
[TBL] [Abstract][Full Text] [Related]
4. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide.
Hofkens W; van den Hoven JM; Pesman GJ; Nabbe KC; Sweep FC; Storm G; van den Berg WB; van Lent PL
Int J Pharm; 2011 Sep; 416(2):493-8. PubMed ID: 21382459
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
[TBL] [Abstract][Full Text] [Related]
6. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis.
van den Hoven JM; Hofkens W; Wauben MH; Wagenaar-Hilbers JP; Beijnen JH; Nuijen B; Metselaar JM; Storm G
Int J Pharm; 2011 Sep; 416(2):471-7. PubMed ID: 21440612
[TBL] [Abstract][Full Text] [Related]
8. Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress.
Alupei MC; Licarete E; Patras L; Banciu M
Cancer Lett; 2015 Jan; 356(2 Pt B):946-52. PubMed ID: 25444912
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
Banciu M; Metselaar JM; Schiffelers RM; Storm G
Neoplasia; 2008 Feb; 10(2):108-17. PubMed ID: 18283332
[TBL] [Abstract][Full Text] [Related]
10. MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate.
Cittadino E; Ferraretto M; Torres E; Maiocchi A; Crielaard BJ; Lammers T; Storm G; Aime S; Terreno E
Eur J Pharm Sci; 2012 Mar; 45(4):436-41. PubMed ID: 21896328
[TBL] [Abstract][Full Text] [Related]
11. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
Schiffelers RM; Metselaar JM; Fens MH; Janssen AP; Molema G; Storm G
Neoplasia; 2005 Feb; 7(2):118-27. PubMed ID: 15802017
[TBL] [Abstract][Full Text] [Related]
12. The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
Licarete E; Rauca VF; Luput L; Patras L; Sesarman A; Banciu M
Oncol Rep; 2019 Dec; 42(6):2694-2705. PubMed ID: 31578578
[TBL] [Abstract][Full Text] [Related]
13. Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment.
Licarete E; Rauca VF; Luput L; Drotar D; Stejerean I; Patras L; Dume B; Toma VA; Porfire A; Gherman C; Sesarman A; Banciu M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340166
[TBL] [Abstract][Full Text] [Related]
14. Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil.
Banciu M; Schiffelers RM; Storm G
Pharm Res; 2008 Aug; 25(8):1948-55. PubMed ID: 18523874
[TBL] [Abstract][Full Text] [Related]
15. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
16. Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles.
Coimbra M; Rijcken CJ; Stigter M; Hennink WE; Storm G; Schiffelers RM
J Control Release; 2012 Nov; 163(3):361-7. PubMed ID: 23041274
[TBL] [Abstract][Full Text] [Related]
17. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation.
Coimbra M; Banciu M; Fens MH; de Smet L; Cabaj M; Metselaar JM; Storm G; Schiffelers RM
J Control Release; 2010 Dec; 148(3):303-10. PubMed ID: 20869410
[TBL] [Abstract][Full Text] [Related]
18. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
[TBL] [Abstract][Full Text] [Related]
19. The antitumour activities induced by pegylated liposomal cytochalasin D in murine models.
Huang FY; Mei WL; Li YN; Tan GH; Dai HF; Guo JL; Wang H; Huang YH; Zhao HG; Zhou SL; Li L; Lin YY
Eur J Cancer; 2012 Sep; 48(14):2260-9. PubMed ID: 22257793
[TBL] [Abstract][Full Text] [Related]
20. Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis
Sesarman A; Luput L; Rauca VF; Patras L; Licarete E; Meszaros MS; Dume BR; Negrea G; Toma VA; Muntean D; Porfire A; Banciu M
J Liposome Res; 2024 Feb; ():1-12. PubMed ID: 38379249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
